Literature DB >> 19133288

Stage of adoption of the human papillomavirus vaccine among college women.

Jennifer D Allen1, Anshu P Mohllajee, Rachel C Shelton, Megan K D Othus, Holly B Fontenot, Richard Hanna.   

Abstract

BACKGROUND: Certain types of human papillomavirus (HPV) can cause cervical and other cancers. A vaccine that protects against HPV types responsible for 70% of cervical cancers is available to females ages 9-26.
OBJECTIVE: To examine correlates of stage of vaccine adoption among women ages 18-22.
METHODS: In 2007, female students (n=4774) at a New England University in the U.S. were invited to complete an on-line survey that assessed knowledge of HPV, perceived susceptibility, severity, vaccine benefits/barriers, social and subjective norms, and stage of vaccine adoption
RESULTS: 1897 women (40%) responded; complete data were available for 1401. About half (53%) were planning to be vaccinated, 12% had received the vaccine, 15% were undecided, and 7% had decided against vaccination. HPV knowledge was low (mean 58%). In multivariate analyses, social norms was the strongest correlate of stage; each standard deviation increase in social norms score was associated with more than four times the odds of intending to be vaccinated within the next 30 days, compared with those who had decided against vaccination (OR=4.15; 95% CI 2.17-6.36).
CONCLUSIONS: Acceptance of the vaccine was high, although misconceptions about viral transmission, availability of treatment, and the role of Pap tests were common. Perceived norms were strongly associated with intentions. Interventions on college campuses should stress vaccination as a normative behavior, provide information about viral transmission, and stress the role of continued Pap screening.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19133288     DOI: 10.1016/j.ypmed.2008.12.005

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  52 in total

1.  Human Papillomavirus Vaccination Among Young Adult Gay and Bisexual Men in the United States.

Authors:  Paul L Reiter; Annie-Laurie McRee; Mira L Katz; Electra D Paskett
Journal:  Am J Public Health       Date:  2015-01       Impact factor: 9.308

2.  Biopower, Normalization, and HPV: A Foucauldian Analysis of the HPV Vaccine Controversy.

Authors:  Kimberly S Engels
Journal:  J Med Humanit       Date:  2016-09

3.  Human papillomavirus vaccine intent and uptake among female college students.

Authors:  Divya A Patel; Melissa Zochowski; Stephanie Peterman; Amanda F Dempsey; Susan Ernst; Vanessa K Dalton
Journal:  J Am Coll Health       Date:  2012

4.  Translating self-persuasion into an adolescent HPV vaccine promotion intervention for parents attending safety-net clinics.

Authors:  Austin S Baldwin; Deanna C Denman; Margarita Sala; Emily G Marks; L Aubree Shay; Sobha Fuller; Donna Persaud; Simon Craddock Lee; Celette Sugg Skinner; Deborah J Wiebe; Jasmin A Tiro
Journal:  Patient Educ Couns       Date:  2016-11-20

5.  Human papillomavirus vaccine use among adolescent girls and young adult women: an analysis of the 2007 California Health Interview Survey.

Authors:  Jasmin A Tiro; Jennifer Tsui; Heidi M Bauer; Eileen Yamada; Sarah Kobrin; Nancy Breen
Journal:  J Womens Health (Larchmt)       Date:  2012-03-15       Impact factor: 2.681

6.  Knowledge of the HPV vaccine and its association with vaccine uptake among female higher-education students in Greece.

Authors:  Elisavet M Donadiki; Rodrigo Jiménez-García; Valentín Hernández-Barrera; Pilar Carrasco-Garrido; Ana López de Andrés; Isabel Jimenez-Trujillo; Emmanuel G Velonakis
Journal:  Hum Vaccin Immunother       Date:  2012-10-30       Impact factor: 3.452

7.  Predictors of initial uptake of human papillomavirus vaccine uptake among rural Appalachian young women.

Authors:  Baretta R Casey; Richard A Crosby; Robin C Vanderpool; Mark Dignan; Wallace Bates
Journal:  J Prim Prev       Date:  2013-04

8.  Facilitators and barriers HPV unvaccinated girls after 5 years of program implementation.

Authors:  Alberto Firenze; Maria Grazia Laura Marsala; Valentina Bonanno; Marianna Maranto; Clara Ferrara; Lucia Giovannelli; Vincenzo Restivo
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

Review 9.  Integrating clinical, community, and policy perspectives on human papillomavirus vaccination.

Authors:  María E Fernández; Jennifer D Allen; Ritesh Mistry; Jessica A Kahn
Journal:  Annu Rev Public Health       Date:  2010       Impact factor: 21.981

10.  Reasons for non-vaccination against HPV and future vaccination intentions among 19-26 year-old women.

Authors:  Gregory D Zimet; Thomas W Weiss; Susan L Rosenthal; Margaret B Good; Michelle D Vichnin
Journal:  BMC Womens Health       Date:  2010-09-01       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.